Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Preferred Dividend Payments (2023 - 2025)

TriSalus Life Sciences has reported Preferred Dividend Payments over the past 3 years, most recently at -$11.9 million for Q4 2025.

  • For Q4 2025, Preferred Dividend Payments fell 474.75% year-over-year to -$11.9 million; the TTM value through Mar 2026 reached $714000.0, down 87.03%, while the annual FY2024 figure was $3.2 million, 153.42% up from the prior year.
  • Preferred Dividend Payments for Q4 2025 was -$11.9 million at TriSalus Life Sciences, down from $11.9 million in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $11.9 million in Q3 2025 and troughed at -$11.9 million in Q4 2025.
  • A 3-year average of $827700.0 and a median of $800500.0 in 2023 define the central range for Preferred Dividend Payments.
  • On a YoY basis, Preferred Dividend Payments climbed as much as 1387.8% in 2025 and fell as far as 474.75% in 2025.
  • Year by year, Preferred Dividend Payments stood at $800000.0 in 2023, then skyrocketed by 298.5% to $3.2 million in 2024, then tumbled by 474.75% to -$11.9 million in 2025.
  • Business Quant data shows Preferred Dividend Payments for TLSI at -$11.9 million in Q4 2025, $11.9 million in Q3 2025, and $714000.0 in Q2 2025.